Aridis Pharmaceuticals

(OTC) ARDS

Current Price$0.00

Market Cap$8,900

Since IPO (2018)-100%

5 Year-100%

1 Year+100%

1 Month+0%

Aridis Pharmaceuticals Financials at a Glance

Market Cap

$8,900

Revenue (TTM)

$20.06M

Net Income (TTM)

$1.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-42.64 (Low)

Dividend

$0.00

Beta (Volatility)

-42.64 (Low)

Price

$0.00

Volume

11,050

Open

$0.00

Price

$0.00

Volume

11,050

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Dividend

$0.00

Beta (Volatility)

-42.64 (Low)

Price

$0.00

Volume

11,050

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

ARDS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aridis Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Vu L. Truong, PhD

Website

www.aridispharma.com

Headquarters

Los Gatos, CA 95032, US

ARDS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.90K

Shares Outstanding

44.57M

Volume

11.05K

Avg. Volume

6.00K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$29.99M

EBITDA

$29.51M

Operating Cash Flow

$29.13M

Capital Expenditure

$82.00K

Free Cash Flow

$29.21M

Cash & ST Invst.

$4.88M

Total Debt

$6.13M

Aridis Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$417.00K

N/A

Gross Profit

$417.00K

N/A

Gross Margin

100.00%

N/A

Market Cap

$8.90K

N/A

Market Cap/Employee

$240.54

N/A

Employees

N/A

Net Income

$83.00K

+99.1%

EBITDA

$810.00K

+88.9%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

$4.80M

+60.6%

Accounts Receivable

$517.00K

+108.5%

Inventory

$0.00

N/A

Long Term Debt

$854.00K

-82.7%

Short Term Debt

$3.99M

-56.4%

Return on Assets

-2.09%

N/A

Return on Invested Capital

1.35%

N/A

Free Cash Flow

$983.00K

+77.0%

Operating Cash Flow

$983.00K

+77.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AFIBAcutus Medical, Inc.

AFIBAcutus Medical, Inc.$0.00+50.00%

INFIQInfinity Pharmaceuticals, Inc.

INFIQInfinity Pharmaceuticals, Inc.$0.00+0.00%

TRVNTrevena, Inc.

TRVNTrevena, Inc.$0.01+0.00%

BTAXBiostax Corp.

BTAXBiostax Corp.$0.00+0.00%

STABStatera Biopharma, Inc.

STABStatera Biopharma, Inc.$0.00+0.00%

ICCTiCoreConnect Inc.

ICCTiCoreConnect Inc.$0.00+0.00%

LIFSLife Stem Genetics Inc.

LIFSLife Stem Genetics Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About ARDS

What is the current price of Aridis Pharmaceuticals?

Aridis Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Aridis Pharmaceuticals?

Over the past 52 weeks, Aridis Pharmaceuticals has traded between $0.00 and $0.05.

How much debt does Aridis Pharmaceuticals have?

As of the most recent reporting period, Aridis Pharmaceuticals reported total debt of $6.13M.

How much cash does Aridis Pharmaceuticals have on hand?

Aridis Pharmaceuticals reported $5.06M in cash and cash equivalents in its most recent financial results.

What is Aridis Pharmaceuticals’s dividend yield?

Aridis Pharmaceuticals does not currently have a dividend yield.

Aridis Pharmaceuticals

Aridis Pharmaceuticals Financials at a Glance

ARDS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aridis Pharmaceuticals

ARDS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aridis Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARDS

What is the current price of Aridis Pharmaceuticals?

What is the 52-week range for Aridis Pharmaceuticals?

How much debt does Aridis Pharmaceuticals have?

How much cash does Aridis Pharmaceuticals have on hand?

What is Aridis Pharmaceuticals’s dividend yield?

Premium Investing Services